Copyright Reports & Markets. All rights reserved.

Global Tiopronin Powder Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Tiopronin Powder Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 0.1g per Bottle
    • 1.3.3 0.2g per Bottle
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Tiopronin Powder Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Alcoholic Fatty Liver
    • 1.4.3 Fatty Liver
    • 1.4.4 Hepatitis
    • 1.4.5 Drug-induced Liver Injury
    • 1.4.6 Other
  • 1.5 Global Tiopronin Powder Injection Market Size & Forecast
    • 1.5.1 Global Tiopronin Powder Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Tiopronin Powder Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Tiopronin Powder Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Cycle Pharma
    • 2.1.1 Cycle Pharma Details
    • 2.1.2 Cycle Pharma Major Business
    • 2.1.3 Cycle Pharma Tiopronin Powder Injection Product and Services
    • 2.1.4 Cycle Pharma Tiopronin Powder Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Cycle Pharma Recent Developments/Updates
  • 2.2 Mission Pharmacal
    • 2.2.1 Mission Pharmacal Details
    • 2.2.2 Mission Pharmacal Major Business
    • 2.2.3 Mission Pharmacal Tiopronin Powder Injection Product and Services
    • 2.2.4 Mission Pharmacal Tiopronin Powder Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Mission Pharmacal Recent Developments/Updates
  • 2.3 AdvaCare Pharma
    • 2.3.1 AdvaCare Pharma Details
    • 2.3.2 AdvaCare Pharma Major Business
    • 2.3.3 AdvaCare Pharma Tiopronin Powder Injection Product and Services
    • 2.3.4 AdvaCare Pharma Tiopronin Powder Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 AdvaCare Pharma Recent Developments/Updates
  • 2.4 Shanxi Zhendong Taisheng Pharmaceutical
    • 2.4.1 Shanxi Zhendong Taisheng Pharmaceutical Details
    • 2.4.2 Shanxi Zhendong Taisheng Pharmaceutical Major Business
    • 2.4.3 Shanxi Zhendong Taisheng Pharmaceutical Tiopronin Powder Injection Product and Services
    • 2.4.4 Shanxi Zhendong Taisheng Pharmaceutical Tiopronin Powder Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Shanxi Zhendong Taisheng Pharmaceutical Recent Developments/Updates
  • 2.5 Hainan Quanxing Pharmaceuticals
    • 2.5.1 Hainan Quanxing Pharmaceuticals Details
    • 2.5.2 Hainan Quanxing Pharmaceuticals Major Business
    • 2.5.3 Hainan Quanxing Pharmaceuticals Tiopronin Powder Injection Product and Services
    • 2.5.4 Hainan Quanxing Pharmaceuticals Tiopronin Powder Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Hainan Quanxing Pharmaceuticals Recent Developments/Updates
  • 2.6 Yuekang Pharmaceutical
    • 2.6.1 Yuekang Pharmaceutical Details
    • 2.6.2 Yuekang Pharmaceutical Major Business
    • 2.6.3 Yuekang Pharmaceutical Tiopronin Powder Injection Product and Services
    • 2.6.4 Yuekang Pharmaceutical Tiopronin Powder Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Yuekang Pharmaceutical Recent Developments/Updates
  • 2.7 Ma'anshan Fengyuan Pharmaceutical
    • 2.7.1 Ma'anshan Fengyuan Pharmaceutical Details
    • 2.7.2 Ma'anshan Fengyuan Pharmaceutical Major Business
    • 2.7.3 Ma'anshan Fengyuan Pharmaceutical Tiopronin Powder Injection Product and Services
    • 2.7.4 Ma'anshan Fengyuan Pharmaceutical Tiopronin Powder Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Ma'anshan Fengyuan Pharmaceutical Recent Developments/Updates
  • 2.8 Yuanda Pharmaceutical
    • 2.8.1 Yuanda Pharmaceutical Details
    • 2.8.2 Yuanda Pharmaceutical Major Business
    • 2.8.3 Yuanda Pharmaceutical Tiopronin Powder Injection Product and Services
    • 2.8.4 Yuanda Pharmaceutical Tiopronin Powder Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Yuanda Pharmaceutical Recent Developments/Updates
  • 2.9 Shenyang Xinma Pharmaceutica
    • 2.9.1 Shenyang Xinma Pharmaceutica Details
    • 2.9.2 Shenyang Xinma Pharmaceutica Major Business
    • 2.9.3 Shenyang Xinma Pharmaceutica Tiopronin Powder Injection Product and Services
    • 2.9.4 Shenyang Xinma Pharmaceutica Tiopronin Powder Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Shenyang Xinma Pharmaceutica Recent Developments/Updates
  • 2.10 Wuhan Hiteck Biological Pharma
    • 2.10.1 Wuhan Hiteck Biological Pharma Details
    • 2.10.2 Wuhan Hiteck Biological Pharma Major Business
    • 2.10.3 Wuhan Hiteck Biological Pharma Tiopronin Powder Injection Product and Services
    • 2.10.4 Wuhan Hiteck Biological Pharma Tiopronin Powder Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Wuhan Hiteck Biological Pharma Recent Developments/Updates
  • 2.11 Hangzhou Zhongmei Huadong Pharmaceutical
    • 2.11.1 Hangzhou Zhongmei Huadong Pharmaceutical Details
    • 2.11.2 Hangzhou Zhongmei Huadong Pharmaceutical Major Business
    • 2.11.3 Hangzhou Zhongmei Huadong Pharmaceutical Tiopronin Powder Injection Product and Services
    • 2.11.4 Hangzhou Zhongmei Huadong Pharmaceutical Tiopronin Powder Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments/Updates
  • 2.12 Shandong Sino Pharmaceutical Technology
    • 2.12.1 Shandong Sino Pharmaceutical Technology Details
    • 2.12.2 Shandong Sino Pharmaceutical Technology Major Business
    • 2.12.3 Shandong Sino Pharmaceutical Technology Tiopronin Powder Injection Product and Services
    • 2.12.4 Shandong Sino Pharmaceutical Technology Tiopronin Powder Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Shandong Sino Pharmaceutical Technology Recent Developments/Updates

3 Competitive Environment: Tiopronin Powder Injection by Manufacturer

  • 3.1 Global Tiopronin Powder Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Tiopronin Powder Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Tiopronin Powder Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Tiopronin Powder Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Tiopronin Powder Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Tiopronin Powder Injection Manufacturer Market Share in 2025
  • 3.5 Tiopronin Powder Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Tiopronin Powder Injection Market: Region Footprint
    • 3.5.2 Tiopronin Powder Injection Market: Company Product Type Footprint
    • 3.5.3 Tiopronin Powder Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Tiopronin Powder Injection Market Size by Region
    • 4.1.1 Global Tiopronin Powder Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Tiopronin Powder Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Tiopronin Powder Injection Average Price by Region (2021-2032)
  • 4.2 North America Tiopronin Powder Injection Consumption Value (2021-2032)
  • 4.3 Europe Tiopronin Powder Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Tiopronin Powder Injection Consumption Value (2021-2032)
  • 4.5 South America Tiopronin Powder Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Tiopronin Powder Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Tiopronin Powder Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Tiopronin Powder Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Tiopronin Powder Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Tiopronin Powder Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Tiopronin Powder Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Tiopronin Powder Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Tiopronin Powder Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Tiopronin Powder Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Tiopronin Powder Injection Market Size by Country
    • 7.3.1 North America Tiopronin Powder Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Tiopronin Powder Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Tiopronin Powder Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Tiopronin Powder Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Tiopronin Powder Injection Market Size by Country
    • 8.3.1 Europe Tiopronin Powder Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Tiopronin Powder Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Tiopronin Powder Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Tiopronin Powder Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Tiopronin Powder Injection Market Size by Region
    • 9.3.1 Asia-Pacific Tiopronin Powder Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Tiopronin Powder Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Tiopronin Powder Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Tiopronin Powder Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Tiopronin Powder Injection Market Size by Country
    • 10.3.1 South America Tiopronin Powder Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Tiopronin Powder Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Tiopronin Powder Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Tiopronin Powder Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Tiopronin Powder Injection Market Size by Country
    • 11.3.1 Middle East & Africa Tiopronin Powder Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Tiopronin Powder Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Tiopronin Powder Injection Market Drivers
  • 12.2 Tiopronin Powder Injection Market Restraints
  • 12.3 Tiopronin Powder Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Tiopronin Powder Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Tiopronin Powder Injection
  • 13.3 Tiopronin Powder Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Tiopronin Powder Injection Typical Distributors
  • 14.3 Tiopronin Powder Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Tiopronin Powder Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Tiopronin is a medication used primarily to treat cystinuria,a condition characterized by the formation of cystine stones in the kidneys and urinary tract.It is available in powder form for injection.
    This report is a detailed and comprehensive analysis for global Tiopronin Powder Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Tiopronin Powder Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Tiopronin Powder Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Tiopronin Powder Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Tiopronin Powder Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Tiopronin Powder Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Tiopronin Powder Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cycle Pharma, Mission Pharmacal, AdvaCare Pharma, Shanxi Zhendong Taisheng Pharmaceutical, Hainan Quanxing Pharmaceuticals, Yuekang Pharmaceutical, Ma'anshan Fengyuan Pharmaceutical, Yuanda Pharmaceutical, Shenyang Xinma Pharmaceutica, Wuhan Hiteck Biological Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Tiopronin Powder Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    0.1g per Bottle
    0.2g per Bottle
    Market segment by Application
    Alcoholic Fatty Liver
    Fatty Liver
    Hepatitis
    Drug-induced Liver Injury
    Other
    Major players covered
    Cycle Pharma
    Mission Pharmacal
    AdvaCare Pharma
    Shanxi Zhendong Taisheng Pharmaceutical
    Hainan Quanxing Pharmaceuticals
    Yuekang Pharmaceutical
    Ma'anshan Fengyuan Pharmaceutical
    Yuanda Pharmaceutical
    Shenyang Xinma Pharmaceutica
    Wuhan Hiteck Biological Pharma
    Hangzhou Zhongmei Huadong Pharmaceutical
    Shandong Sino Pharmaceutical Technology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Tiopronin Powder Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Tiopronin Powder Injection, with price, sales quantity, revenue, and global market share of Tiopronin Powder Injection from 2021 to 2026.
    Chapter 3, the Tiopronin Powder Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Tiopronin Powder Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Tiopronin Powder Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Tiopronin Powder Injection.
    Chapter 14 and 15, to describe Tiopronin Powder Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now